INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 111 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $241,000 | -81.7% | 70,431 | -84.0% | 0.03% | -82.3% |
| Q2 2021 | $1,320,000 | -22.9% | 441,473 | -16.7% | 0.19% | -44.1% |
| Q1 2021 | $1,712,000 | +5606.7% | 530,000 | +2255.6% | 0.33% | +16550.0% |
| Q2 2016 | $30,000 | -88.2% | 22,500 | -25.0% | 0.00% | -80.0% |
| Q3 2015 | $254,000 | +247.9% | 30,000 | +451.7% | 0.01% | +233.3% |
| Q3 2014 | $73,000 | -92.5% | 5,438 | -92.2% | 0.00% | -95.2% |
| Q4 2013 | $967,000 | +104.0% | 70,000 | +139.8% | 0.06% | +93.8% |
| Q2 2013 | $474,000 | – | 29,188 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 17,426,968 | $36,945,000 | 1.45% |
| Opaleye Management Inc. | 3,171,800 | $6,724,000 | 0.88% |
| EAM Investors, LLC | 421,103 | $893,000 | 0.15% |
| Bleichroeder LP | 250,000 | $530,000 | 0.10% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 755,593 | $1,602,000 | 0.04% |
| Callan Capital, LLC | 73,200 | $155,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 419,300 | $889,000 | 0.02% |
| Private Wealth Advisors, Inc. | 12,000 | $25,000 | 0.01% |
| Alpine Global Management, LLC | 24,575 | $52,000 | 0.01% |
| Evercore Wealth Management, LLC | 143,138 | $303,000 | 0.01% |